These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4455518)

  • 1. [European patent].
    Saviotti G
    Farmaco Prat; 1974 Jan; 29(1):18-20. PubMed ID: 4455518
    [No Abstract]   [Full Text] [Related]  

  • 2. [COMPARISON OF 2 BILLS ON PHARMACEUTICAL PATENTING IN ITALY, THE EUROPEAN PATENT BILL AND THE GERMAN, ENGLISH AND UNITED STATES LAWS ON PATENTS OF INVENTIONS].
    BELLENGHI M
    Farmaco Prat; 1964 May; 19():240-51. PubMed ID: 14167551
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of patent abolition on the drug industry.
    SMITH A
    Appl Ther; 1963 May; 5():433-7. PubMed ID: 13993111
    [No Abstract]   [Full Text] [Related]  

  • 4. European Commission's inquiry into the pharmaceuticals sector.
    Ager B
    Lancet; 2009 Nov; 374(9704):1819; author reply 1819-20. PubMed ID: 19944861
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent alert.
    IDrugs; 2003 Aug; 6(8):811-9. PubMed ID: 12971396
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent alert.
    Noprman P; Whelan C; Press N
    IDrugs; 2003 Dec; 6(12):1198-1204. PubMed ID: 14712832
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2005 Jun; 8(6):508-10. PubMed ID: 15966134
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2003 Jan; 6(1):79-81. PubMed ID: 12838979
    [No Abstract]   [Full Text] [Related]  

  • 9. The people vs patents.
    New Sci; 2002 Jul; 175(2351):3. PubMed ID: 12625337
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent watch: Progress in three key patent disputes in 2009.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of patent term restoration to pharmaceutical innovation.
    Hutt PB
    Health Aff (Millwood); 1982; 1(2):6-24. PubMed ID: 7185724
    [No Abstract]   [Full Text] [Related]  

  • 13. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogen will patent interferon product.
    N Y Times Web; 1984 Feb; ():D4. PubMed ID: 11646346
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of drug patent abolition on a Canadian pharmaceutical company.
    LOZINSKI E
    Appl Ther; 1963 May; 5():441-2. PubMed ID: 13931335
    [No Abstract]   [Full Text] [Related]  

  • 16. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent filing strategies for pharmaceuticals in Europe.
    Höpfner S
    Pharm Pat Anal; 2014; 3(6):563-5. PubMed ID: 25489909
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 19. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent indicators: a window to pharmaceutical market success.
    Guo Y; Hu Y; Zheng M; Wang Y
    Expert Opin Ther Pat; 2013 Jul; 23(7):765-71. PubMed ID: 23611022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.